India markets closed
  • BSE SENSEX

    52,975.80
    +138.59 (+0.26%)
     
  • Nifty 50

    15,856.05
    +32.00 (+0.20%)
     
  • USD/INR

    74.4250
    -0.0250 (-0.03%)
     
  • Dow

    35,061.55
    +238.20 (+0.68%)
     
  • Nasdaq

    14,836.99
    +152.39 (+1.04%)
     
  • BTC-INR

    2,521,773.50
    +107,525.50 (+4.45%)
     
  • CMC Crypto 200

    786.33
    -7.40 (-0.93%)
     
  • Hang Seng

    27,321.98
    -401.86 (-1.45%)
     
  • Nikkei

    27,548.00
    +159.80 (+0.58%)
     
  • EUR/INR

    87.6338
    -0.0146 (-0.02%)
     
  • GBP/INR

    102.3076
    -0.1833 (-0.18%)
     
  • AED/INR

    20.2200
    -0.0050 (-0.02%)
     
  • INR/JPY

    1.4824
    +0.0055 (+0.37%)
     
  • SGD/INR

    54.7280
    -0.0460 (-0.08%)
     

Outlook on the Femtech Global Market to 2026 - Growing Availability of Smart Medical Devices for Women Presents Opportunities

·8-min read

Dublin, June 15, 2021 (GLOBE NEWSWIRE) -- The "Femtech Market - Global Outlook and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

The femtech market is expected to grow at a CAGR of over 13% during the forecast period 2020-2026.

The healthcare market is entering the era of digital innovation as patients seek on-demand healthcare. It is estimated that 80% of women spend on health products and make 90% of household decisions on health issues. Developers in healthcare have introduced female technology, which is broadly termed femtech. The usage of medical apps is increasing as it creates health awareness, health coaching, and medication management to technology-enabled solutions for accurate screening and diagnosis of chronic diseases; femtech applications covers major areas of healthcare.

Healthcare professionals are in the pipeline to create better workflows using artificial intelligence-powered systems. With the wide acceptance of digital transformation in the healthcare market, several femtech companies focus on collecting their health data from medical devices, including wearable technology. As most of the technologies are implemented in femtech products, the rise in demand for these solutions can enhance the market's growth.

The following factors are likely to contribute to the growth of the femtech market during the forecast period:

  • Latest approaches for preventing female-specific chronic conditions

  • Advancements of smart medical devices & wearables for women

  • Rising demand for digital health solutions

  • Growing interest of venture capitalists

The report considers the present scenario of the femtech market and its market dynamics for the period 2020-2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market.

The demand for smart medical devices with more comfort and reduced side effects is gaining traction in female-focused health products. Femtech investors, fitness wearable manufacturers, and health advocates should focus on creating solutions for the entire spectrum of women. Clue offers fertility tracking solutions collaborating with Fitbit's ionic sports watch to make the first-period tracking app compatible with the Fitbit OS.

Femtech assists women through pre-pregnancy, pregnancy to the post-pregnancy stage. Latest technology solutions can help with newborn baby health monitoring and nursing care. Many startups are creating innovative digital technologies incorporated into the femtech products, thereby driving the market's growth. A female-founded startup addressing women's sexual health is Rosy, a digital health solution supporting women experiencing low libido. The global femtech market by maternal health is expected to reach over USD 19 billion by 2026. Many devices, wearables, applications have been developed to monitor body changes in pregnant women and prenatal care. Bloomlife, Luna, Lucina, Obseva, Inpress Technologies, and many others are providing pregnancy-related services.

Technological advancements can keep women informed about their health issues and be managed efficiently. Diagnostic and screening services are mostly performed by using medical devices specific for diagnosing female health conditions. Endodiag, a French medical technology company that allows early diagnosis of endometriosis, and iSono Health developed a screening device for breast cancer. Femtech devices gaining significance in this sector include Bellabeat Leaf, which allows women to track, manage, and improve their overall health. CareNX Innovations provides smartphone-integrated care diagnostics making it highly accessible to women in rural areas.

Government and NHS authorities are funding the end-users to increase the consumption of femtech products. Among various end-users, hospitals and surgical centers have the highest adoption of femtech products and services, contributing a significant share in the market. The acceptance of personalized diagnostics, smart tools, and evidence-based recommendations are changing the way women's health issues are addressed.

The use of artificial intelligence and data analytics in diagnostics can improve the effectiveness of screening and diagnosis. Most tech companies and investors focused on fertility and maternity management, such as Natalist, which offers DTC products for fertility, pregnancy, and educational information.

Key Questions Answered

  • How big is the femtech market?

  • What is the growth rate of the US femtech market?

  • What are the key technologies driving the Femtech Market?

  • How is COVID-19 enabling the femtech market growth?

  • Which end-user segment is the fastest growing in the femtech market?

Key Topics Covered:

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope of The Study
4.3.1 Market Segmentation by Product Type
4.3.2 Market Segmentation by Indication
4.3.3 Market Segmentation by Application
4.3.4 Market Segmentation by End-user
4.3.5 Market Segmentation By Geography

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 Market at a Glance

7 Introduction
7.1 Overview
7.1.1 Women in Healthcare (Global)
7.1.2 Three Waves of Femtech Evolution
7.1.3 Future Wave & Opportunities in Femtech

8 Market Opportunities & Trends
8.1 Growing Interest of Venture Capitalists
8.2 Growing Availability Of Smart Medical Devices For Women
8.3 Increasing Sexual & Reproductive Awareness Due To Digital Technologies
8.4 Inclusive Care For Queer Communities Through Femtech

9 Market Growth Enablers
9.1 Preventing Female-Specific Chronic Conditions
9.2 Increasing Demand For Digital Health Solutions
9.3 Role Of Women In Increasing Traction Toward Femtech
9.4 Large Growth Potential In Femtech Services

10 Market Restraints
10.1 Low Adoption of Digital Technologies In Rural Areas
10.2 Societal Myths & Taboos Surrounding Women's Health
10.3 Lack of Awareness About Reproductive Health & Menstrual Hygiene

11 Market Landscape

12 Product Type

13 Indication

14 Application

15 End-User

16 Geography

17 North America

18 Europe

19 APAC

20 Latin America

21 Middle East & Africa

22 Competitive Landscape
22.1 Competition Overview

23 Prominent Vendors
23.1 ALYK
23.1.1 Business Overview
23.1.2 Product Offerings
23.2 ASPIVIX
23.2.1 Business Overview
23.2.2 Product Offerings
23.3 Athena Feminine Technologies
23.3.1 Business Overview
23.3.2 Product Offerings
23.4 Ava Science
23.4.1 Business Overview
23.4.2 Product Offerings
23.5 Clue By Biowink Gmbh
23.5.1 Business Overview
23.5.2 Product Offerings
23.6 Bloomer Tech
23.6.1 Business Overview
23.6.2 Product Offerings
23.7 Bloomlife
23.7.1 Business Overview
23.7.2 Product Offerings
23.8 Bonzun IVF
23.8.1 Business Overview
23.8.2 Product Offerings
23.9 Calla Lily Personal Care
23.9.1 Business Overview
23.9.2 Product Offerings
23.10 Cororointim SL
23.10.1 Business Overview
23.10.2 Product Offerings
23.11 Cirqle Biomedical
23.11.1 Business Overview
23.11.2 Product Offerings
23.12 Daye
23.12.1 Business Overview
23.12.2 Product Offerings
23.13 Elvie
23.13.1 Business Overview
23.13.2 Product Offerings
23.14 Emjoy
23.14.1 Business Overview
23.14.2 Product Offerings
23.15 Femcy
23.15.1 Business Overview
23.15.2 Product Offerings
23.16 Fizimed
23.16.1 Business Overview
23.16.2 Product Offerings
23.17 FLO Health
23.17.1 Business Overview
23.17.2 Product Offerings
23.18 FREDA
23.18.1 Business Overview
23.18.2 Product Offerings
23.19 Glow
23.19.1 Business Overview
23.19.2 Product Offerings
23.20 Grace Health
23.20.1 Business Overview
23.20.2 Product Offerings
23.21 Heramed
23.21.1 Business Overview
23.21.2 Product Offerings
23.22 INNE
23.22.1 Business Overview
23.22.2 Product Offerings
23.23 Isono Health
23.23.1 Business Overview
23.23.2 Product Offerings
23.24 Joylux
23.24.1 Business Overview
23.24.2 Product Offerings
23.25 Juno Bio
23.25.1 Business Overview
23.25.2 Product Offerings
23.26 Kasha
23.26.1 Business Overview
23.26.2 Product Offerings
23.27 LACTAPP
23.27.1 Business Overview
23.27.2 Product Offerings
23.28 Minerva Surgical
23.28.1 Business Overview
23.28.2 Product Offerings
23.29 Moody Month
23.29.1 Business Overview
23.29.2 Product Offerings
23.30 Natural Cycles
23.30.1 Business Overview
23.30.2 Product Offerings
23.31 Nurx
23.31.1 Business Overview
23.31.2 Product Offerings
23.32 Nuvo
23.32.1 Business Overview
23.32.2 Product Offerings
23.33 Nvision Medical
23.33.1 Business Overview
23.33.2 Product Offerings
23.34 Peanut
23.34.1 Business Overview
23.34.2 Product Offerings
23.35 Tempdrop
23.35.1 Business Overview
23.35.2 Product Offerings
23.36 Thinx
23.36.1 Business Overview
23.36.2 Product Offerings
23.37 Totohealth
23.37.1 Business Overview
23.37.2 Product Offerings
23.38 Univfy
23.38.1 Business Overview
23.38.2 Product Offerings
23.39 Willow
23.39.1 Business Overview
23.39.2 Product Offerings
23.40 WOOM
23.40.1 Business Overview
23.40.2 Product Offerings

24 Report Summary

25 Quantitative Summary

26 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/hj06p6

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting